Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,855 JPY | +1.72% | +4.47% | +8.44% |
Feb. 13 | LIM Advisors Partially Withdraws Shareholder Proposal | CI |
Feb. 09 | Torii Pharmaceuticals Opposes Shareholder Proposal | CI |
Sales 2024 * | 57.8B 365M | Sales 2025 * | 61.22B 386M | Capitalization | 108B 683M |
---|---|---|---|---|---|
Net income 2024 * | 4.88B 30.84M | Net income 2025 * | 5.65B 35.69M | EV / Sales 2024 * | 1.87 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.77 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
19.2
x | Employees | 583 |
Yield 2024 * |
3.11% | Yield 2025 * |
3.11% | Free-Float | 42.17% |
1 day | +1.72% | ||
1 week | +4.47% | ||
Current month | -5.86% | ||
1 month | -6.77% | ||
3 months | +1.98% | ||
6 months | +5.33% | ||
Current year | +8.44% |
Managers | Title | Age | Since |
---|---|---|---|
Goichi Matsuda
PSD | President | 57 | 17-02-28 |
Director of Finance/CFO | - | - | |
Megumi Kajiwara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 60 | 87-03-31 | |
Masao Torikai
BRD | Director/Board Member | 61 | 10-05-31 |
Masaki Sunami
PRN | Corporate Officer/Principal | 65 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 15 M€ | +7.34% | ||
0.05% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - | |
0.01% | 18 M€ | +16.15% | - | |
0.01% | 20,721 M€ | +13.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3,855 | +1.72% | 48,200 |
24-04-25 | 3,790 | +0.80% | 39,500 |
24-04-24 | 3,760 | -0.53% | 18,900 |
24-04-23 | 3,780 | +0.40% | 14,900 |
24-04-22 | 3,765 | +2.03% | 20,100 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.44% | 688M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4551 Stock